Seeking Alpha
 

Acorda Therapeutics, Inc. (ACOR)

- NASDAQ
  • Michael Hagan | Send Message 24 Feb

    Acorda 2015: Patents, Pipeline & Patients; Cash & Catalysts $ACOR http://seekingalpha.com/a/1r1ha
    Reply
      • Clinically Sound Investor | Send Message 24 Feb

        Acorda Therapeutics: 2015 Growth Estimates Are Fair $ACOR http://seekingalpha.com/a/1r2tm
        Reply
          • Jim Van Meerten | Send Message 8 Jan

            Acorda Therapeutics - Barchart's Chart Of The Day $ACOR http://seekingalpha.com/p/25mc9
            Reply
              • LaboMedic | Send Message 5 Jan

                $ACOR Acorda Therapeutics: Lack Of Meaningful Catalysts Anticipated In 2015, Says J.P. Morgan http://bit.ly/1rYDgBG
                Reply
                  • bobzic | Send Message 10 Dec 2014

                    The mode of administration of $CYNAF seems more appropriate to me compared to $ACOR
                    Reply (1)
                    • bobzic | Send Message 10 Dec 2014
                      : I am long $CYNAF.
                      • Michael Hagan | Send Message 25 Nov 2014

                        Cynapsus Or Acorda - Whose Market Is It For Parkinson's Disease? $ACOR http://seekingalpha.com/a/1m0d9
                        Reply (2)
                        • bobzic | Send Message 10 Dec 2014
                          : My favorite is $CYNAF
                        • bobzic | Send Message 10 Dec 2014
                          : The mode of administration of $CYNAF seems more appropriate to me.
                          • Stock Traders Daily | Send Message 12 Nov 2014

                            Acorda Growth Is Expected To Stall $ACOR http://seekingalpha.com/a/1lbah
                            Reply
                              • Michael Hagan | Send Message 1 Nov 2014

                                Acorda Therapeutics Hitting Its Stride As Company Momentum Accelerates $ACOR http://seekingalpha.com/a/1k829
                                Reply
                                  • Michael Hagan | Send Message 8 Oct 2014

                                    See my NeuroDerm article for further discussion on $CYNAF and $ACOR "rescue" therapies.
                                    Reply
                                      • LaboMedic | Send Message 24 Sep 2014

                                        $ACOR Cowen Maintains Bullish Stance On Acorda In Light Of Civitas Acquisition; Raises PT To $65 http://bit.ly/1rkBMOo
                                        Reply
                                          Visit Seeking Alpha's
                                          ACOR vs. ETF Alternatives
                                          Company Description
                                          Acorda Therapeutics Inc is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment ofneurological disorders.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States